News Feature | June 19, 2014

John Wiley & Sons Inc. Acquires SimBioSys

By Marcus Johnson

beakermoney_450x300

John Wiley Sons Inc. has announced that it has acquired SimBioSys Inc. Wiley is a global provider of knowledge-based services that help improve research and professional outcomes. Wiley is particularly focused on areas such as science, technology, medicine, advertising, and database services. Wiley also provides digital and print content, as well as education solutions such as online program management. The company acquired SimBioSys, which primarily focuses on the field of computer-aided retrosynthetic analysis. SimBioSys helps chemists through the challenges of organic synthesis. SimBioSys has long been recognized in the field of rational drug discovery software.

Steve Miron, the senior vice president of Wiley’s global research business, released a statement on the move. “Wiley has deep roots in top quality chemistry publishing with high-profile international chemistry society partnerships and extensive chemical databases, journals, books and references,” said Miron. “By combining our traditional published content and databases with machine learning algorithms, we can support chemists in innovative research as they advance world knowledge.”

Dr. Mike Davis, vice president and managing director of research innovations at Wiley, also commented on the acquisition. “The acquisition of SimBioSys accelerates the development of Wiley Science Solutions, our integrated suite of workflow tools for researchers,” he said. “SymBioSys has developed technology that enables the computer to learn organic chemistry. These tools enable chemists working in industry and academia to find new and better ways of synthesizing target compounds, saving them time and money.”

Experts believe that SimBioSys’s ARChem Route Designer will be of importance to chemists. The system is designed to help chemists create viable synthetic routes for target molecules. Wiley believes that its CIRX Reaction Database will be able to make the SimBioSys system more comprehensive, as the ARChem currently derives its knowledge of organic chemistry from similar reaction databases.